FTC sues big pharmacy gain managers over insulin charges The agency introduced motion against Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record cost of existence-preserving insulin prescription drugs. Investment in digital wellness organizations achieved several years-small ranges past 12 months soon https://kethek.com/